These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18428551)

  • 1. Preclinical models of hepatic encephalopathy.
    Basile AS; Mullen K
    Curr Protoc Neurosci; 2001 May; Chapter 9():Unit9.3. PubMed ID: 18428551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
    Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain edema in acute liver failure. Insight from experimental studies.
    Andres T; Blei MD; Judy R; Cho MD
    Rev Invest Clin; 1990 Jul; 42 Suppl():127-30. PubMed ID: 19256151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha.
    Chu CJ; Chen CT; Wang SS; Lee FY; Chang FY; Lin HC; Wu SL; Lu RH; Chan CC; Huang HC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):321-30. PubMed ID: 11534799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
    Fischer JE
    Arch Surg; 1974 Mar; 108(3):325-36. PubMed ID: 4149791
    [No Abstract]   [Full Text] [Related]  

  • 6. [Porto-caval encephalopathy (author's transl)].
    Delcourt A
    Rev Med Brux; 1980 Apr; 1(4):241-5. PubMed ID: 7466022
    [No Abstract]   [Full Text] [Related]  

  • 7. [70% hepatectomy and portacaval termino-lateral anastomosis as an experimental model of fulminating hepatic insufficiency].
    Cuervas-Mons V; Golitsin A; Cienfuegos JA; Maganto P; Eroles G; Castillo-Olivares JL
    Rev Esp Enferm Apar Dig; 1983 Nov; 64(5):389-94. PubMed ID: 6658131
    [No Abstract]   [Full Text] [Related]  

  • 8. Spatial memory alterations in three models of hepatic encephalopathy.
    Méndez M; Méndez-López M; López L; Aller MA; Arias J; Cimadevilla JM; Arias JL
    Behav Brain Res; 2008 Mar; 188(1):32-40. PubMed ID: 18063138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of portal hypertension.
    Bengmark S
    Clin Gastroenterol; 1975 May; 4(2):395-423. PubMed ID: 1092492
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of portal hypertension. Indications for and methods of portacaval shunt in the cirrhotic patient].
    Maillard JN; Flamant Y
    Minerva Med; 1978 Apr; 69(17):1167-70. PubMed ID: 662146
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic encephalopathy in surgical treatment of patients with portal hypertension].
    Lebezev VM; Gubskiĭ LV; Tachmuradova GT; Dolidze MA
    Klin Med (Mosk); 1995; 73(2):37-9. PubMed ID: 7609415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental studies of the pathomechanism of portal encephalopathy. II. Monoamine oxidase (MAO) activity in the rat brain after porta- caval shunt using 2 different methods].
    Rokicki M; Rokicki W; Tarnawski R; Gebska E; Peciak B
    Neuropatol Pol; 1989; 27(2):209-16. PubMed ID: 2696882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for portal hypertension.
    Kern KA; Bower RH; Fischer JE
    Semin Liver Dis; 1982 Aug; 2(3):242-54. PubMed ID: 6758122
    [No Abstract]   [Full Text] [Related]  

  • 15. Associative learning deficit in two experimental models of hepatic encephalopathy.
    Méndez M; Méndez-López M; López L; Aller MA; Arias J; Arias JL
    Behav Brain Res; 2009 Mar; 198(2):346-51. PubMed ID: 19056427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
    Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
    J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Free aminoacids and cerebral lipids in the rat following porto-cava anastomosis].
    Vassanelli P; Stella GD; Pelizzo MR; Rizzi B; Bertani G
    Arch Sci Med (Torino); 1973; 130(3):198-202. PubMed ID: 17342915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of an animal model of hepatic encephalopathy.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Wu SL; Chan CC; Tsai YT; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):263-9. PubMed ID: 10820904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin for thioacetamide-induced hepatic failure and encephalopathy.
    Huang HC; Chang CC; Wang SS; Chan CY; Lee FY; Chuang CL; Hsin IF; Teng TH; Lin HC; Lee SD
    Eur J Clin Invest; 2012 Feb; 42(2):139-45. PubMed ID: 21749370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
    Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.